Liver transplantation is the standard of care for patients with decompensated cirrhosis. Liver transplantation recipients have excellent short-term and long-term outcomes including patient and graft survival. Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal disease has risen significantly. Occurrence of Stage 4 chronic kidney disease and end stage renal disease substantially increases the risk of post-transplant deaths. Because majority of late post-transplant mortality is due to nonhepatic post-transplant comorbidities, personalized care directed toward risk factor modification may further improve post-transplant survival. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.
机构:
Northwestern Univ, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA
Northwestern Univ, Div Organ Transplantat, Feinberg Sch Med, Chicago, IL 60611 USANorthwestern Univ, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA
Agrawal, Akansha
Ison, Michael G.
论文数: 0引用数: 0
h-index: 0
机构:
Northwestern Univ, Div Organ Transplantat, Feinberg Sch Med, Chicago, IL 60611 USA
Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USANorthwestern Univ, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA
Ison, Michael G.
Danziger-Isakov, Lara
论文数: 0引用数: 0
h-index: 0
机构:
Cincinnati Childrens Hosp Med Ctr, Div Pediat Infect Dis, Cincinnati, OH 45229 USA
Univ Cincinnati, Cincinnati, OH USANorthwestern Univ, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA
Danziger-Isakov, Lara
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2022,
17
(02):
: 286
-
295